Ronit Simantov

Ronit Simantov

Directeur Technique/Scientifique/R&D chez GAMIDA CELL LTD.

Fortune : 9 227 $ au 30/04/2024

59 ans
Health Technology
Consumer Services

Provenance du réseau au premier degré de Ronit Simantov

EntitéType d'entitéIndustrie
Public Company Pharmaceuticals: Major 201
Public Company Pharmaceuticals: Major 34
Private Company Pharmaceuticals: Major 18
Public Company Pharmaceuticals: Major 15
10
Subsidiary Pharmaceuticals: Major 10
5
Subsidiary Biotechnology 5
4
Subsidiary Pharmaceuticals: Major 4

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Ronit Simantov via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Harvard Business School College/University

Ginger Graham

Brian Atwood

Michael Perry

Joshua D. Hamermesh

Robert Azelby

Paulash Mohsen

David Hering

Masters Business Admin

Masters Business Admin

Graduate Degree

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

College/University

Paul Klingenstein

Vatnak Vat-Ho

Anna Berkenblit

William S. Korinek

Ian Taylor

Hong I. Wan

Undergraduate Degree

Undergraduate Degree

Graduate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Stanford University College/University

Edward McKinley

William Steere

Paul Klingenstein

Thomas Woiwode

Marc Tessier-Lavigne

Helen Hobbs

Undergraduate Degree

Undergraduate Degree

Masters Business Admin

Doctorate Degree

President

Undergraduate Degree

University of California, Berkeley College/University

Ginger Graham

Thomas Woiwode

Thomas Dubensky

Sharon Sakai

Hong I. Wan

Nicholas Maestas

Director/Board Member

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Biotechnology

Michael Perry

Kenneth Moch

Yael Margolin

Boaz Lifschitz

Ofer Gonen

Director/Board Member

Director/Board Member

President

Director/Board Member

Director/Board Member

MEDIWOUND LTD. Pharmaceuticals: Major

Stephen Wills

David Fox

Tzvi Palash

Ofer Gonen

Director/Board Member

Director/Board Member

Chief Operating Officer

Chief Executive Officer

Massachusetts Institute of Technology College/University

Julian Adams

Anna Berkenblit

Yi Ning Zhao

Paulash Mohsen

Doctorate Degree

Graduate Degree

Masters Business Admin

Graduate Degree

The Hebrew University of Jerusalem College/University

David Fox

Tzvi Palash

Ofer Gonen

Vladimir Melnikov

Graduate Degree

Graduate Degree

Undergraduate Degree

Graduate Degree

IMMUNE DESIGN CORP Pharmaceuticals: Major

Brian Atwood

Thomas Dubensky

Stephen Brady

Nicholas Maestas

Director/Board Member

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Brian Atwood

Kenneth Moch

Mike Raab Raab

Stephen Brady

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Director/Board Member

College/University

Tzvi Palash

Yael Margolin

Ofer Gonen

Shai Lankry

Undergraduate Degree

Graduate Degree

Graduate Degree

Masters Business Admin

AMGEN INC. Pharmaceuticals: Major

James Blair

Christine Regan Lindenboom

Yi Ning Zhao

Robert Azelby

Director/Board Member

Public Communications Contact

Corporate Officer/Principal

Corporate Officer/Principal

REGENERON PHARMACEUTICALS, INC. Pharmaceuticals: Major

Michael Brown

Robert Landry

Marc Tessier-Lavigne

Director/Board Member

Director of Finance/CFO

Director/Board Member

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Amy Schulman

Olivier Brandicourt

Christine Regan Lindenboom

Chairman

Director/Board Member

Investor Relations Contact

Miscellaneous Commercial Services

Michael Brown

Marc Tessier-Lavigne

Baiyong Li

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Packaged Software

Edmund Harrigan

Amy Schulman

Abbey Jenkins

Director/Board Member

Founder

Corporate Officer/Principal

INFINITY PHARMACEUTICALS, INC. Pharmaceuticals: Major

Julian Adams

Joshua D. Hamermesh

Jaren Madden

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Investor Relations Contact

Yale University College/University

Edward McKinley

Anna Berkenblit

Keith Flaherty

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Biotechnology

Marc Tessier-Lavigne

Richard Fair

Shawn Tomasello

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Bar-Ilan University College/University

Nurit Benjamini

Boaz Lifschitz

Yisrael Gewirtz

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

NOVARTIS AG Pharmaceuticals: Major

Michael Perry

Beth Calitri

James Wassil

Corporate Officer/Principal

Public Communications Contact

Corporate Officer/Principal

Medical Specialties

Mike Raab Raab

Joshua D. Hamermesh

Javier Cote-Sierra

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of Notre Dame College/University

David Wurzer

Robert Landry

James Wassil

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

JUNO THERAPEUTICS INC Biotechnology

Marc Tessier-Lavigne

Robert Azelby

Premal Patel

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Michael Perry

Geoffrey Nichol

Mary Coelho

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

John Mascotte

Amy Schulman

Robert Landry

Director/Board Member

General Counsel

Treasurer

ATRECA, INC. Biotechnology

Brian Atwood

Stephen Brady

Lindsey Rolfe

Chairman

Director/Board Member

Director/Board Member

ELICIO THERAPEUTICS, INC. Biotechnology

Julian Adams

Heather DiVecchia

Chairman

Investor Relations Contact

Miscellaneous Commercial Services

Amy Schulman

Jim Smith

Director/Board Member

Director/Board Member

ELI LILLY AND COMPANY Pharmaceuticals: Major

Ginger Graham

Thorlef Spickschen

Corporate Officer/Principal

Corporate Officer/Principal

GSK PLC Pharmaceuticals: Major

Geoffrey Nichol

Clare Khan

Corporate Officer/Principal

General Counsel

University of Montréal College/University

Martine George

Reina Benabou

Graduate Degree

Doctorate Degree

Biotechnology

Ofer Gonen

Yona Geffen

Director/Board Member

Chief Executive Officer

SANGAMO THERAPEUTICS, INC. Biotechnology

Geoffrey Nichol

Adrian Woolfson

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

University of California, Irvine College/University

Brian Atwood

Richard Margolin

Undergraduate Degree

Doctorate Degree

Boston University School of Medicine College/University

Carl Morris

Susan E. Ward

Corporate Officer/Principal

Doctorate Degree

College/University

M. Anthony Burns

Joseph Echevarria

Director/Board Member

Chief Executive Officer

ZOETIS INC. Pharmaceuticals: Major

Amy Schulman

William Steere

Director/Board Member

Director/Board Member

University of Oxford College/University

Marc Tessier-Lavigne

Adrian Woolfson

Undergraduate Degree

Undergraduate Degree

Biotechnology

Daniel Muehl

Paul Gross

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Ginger Graham

Olivier Brandicourt

Director/Board Member

Chairman

Biotechnology

Julian Adams

Ofer Gonen

Director/Board Member

Director/Board Member

CLAL BIOTECHNOLOGY INDUSTRIES LTD. Financial Conglomerates

Julian Adams

Ofer Gonen

President

Chief Executive Officer

SOLID BIOSCIENCES INC. Biotechnology

Carl Morris

Clare Khan

Chief Tech/Sci/R&D Officer

Director/Board Member

Sandoz Pharmaceuticals Corp.

Michael Perry

Martine George

General Counsel

Corporate Officer/Principal

Statistiques

Internationale

Etats-Unis 38
Israël 8
Royaume-Uni 4
Suisse 2
Canada 2

Sectorielle

Health Technology 29
Consumer Services 15
Commercial Services 4
Finance 3
Technology Services 2

Opérationnelle

Director/Board Member 576
Corporate Officer/Principal 271
Independent Dir/Board Member 173
Undergraduate Degree 84
Chairman 83
  1. Bourse
  2. Insiders
  3. Ronit Simantov
  4. Connexions Sociétés
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT